skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

333 studies were found about Complications/Side Effects, Gastrointestinal (GI) Problems

Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea

Condition: HIV Enteropathy; Diarrhea With HIV

NCT ID: NCT01374490

Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial

Condition: Diarrhea; HIV Infections

NCT ID: NCT00002088

The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients

Condition: HIV Infections; Diarrhea; Bacterial Vaginosis

NCT ID: NCT00536848

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Condition: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting; HIV Infections

NCT ID: NCT00642499

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

Condition: Diarrhea; HIV Infections

NCT ID: NCT00002408

Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

Condition: HIV Associated Diarrhea

NCT ID: NCT00547898

Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya

Condition: HIV Infections; Human Immunodeficiency Virus; Malaria; Plasmodium Falciparum; Diarrhea

NCT ID: NCT00914225

Acupuncture for Nausea in HIV

Condition: HIV Infections

NCT ID: NCT00624793

Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study

Condition: Diarrhea; HIV Infection

NCT ID: NCT01116908

Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea

Condition: Diarrhea; HIV Infections

NCT ID: NCT00002121

A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea

Condition: Diarrhea; HIV Infections

NCT ID: NCT00002252

A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.

Condition: Diarrhea; HIV Infections

NCT ID: NCT00002253

Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Disease Progression; Immune System Diseases; Malaria; Parasitic Diseases; Pneumonia; Diarrhea; Infectious Disorder of Immune System

NCT ID: NCT01425073

Trial of Safe Water Storage Among People Living With HIV

Condition: Diarrhea; Waterborne Disease; HIV

NCT ID: NCT01376336

The Healthy Life Choices Project in HIV-Positive Patients

Condition: Diarrhea; HIV Infections

NCT ID: NCT00017810

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Condition: Acne Vulgaris; Allergic Rhinitis (Disorder); Anxiety; Asthma; Back Pain; Prostatic Hyperplasia; Bursitis; Chronic Obstructive Pulmonary Disease; Cough; Coronary Artery Disease; Depression; Diabetes Mellitus; Diarrhea; Gastroesophageal Reflux; Fibromyalgia; Headache; HIV Infections; Hypothyroidism; Hyperlipidemia; Hypertension; Influenza; Sleep Initiation and Maintenance Disorders; Irritable Bowel Syndrome; Knee Pain; Migraine Disorders; Obesity; Obstructive Sleep Apnea; Osteoarthritis; Senile Osteoporosis; Colonoscopy; Mammography; Shoulder Pain; Sinusitis; Smoking Cessation; Tobacco Use Cessation; Menopause; Urinary Incontinence; Urinary Tract Infection; Vaccination; Vaginitis; Vertigo

NCT ID: NCT01050465

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

Condition: Cytomegalovirus Retinitis; HIV Infections; Gastrointestinal Diseases

NCT ID: NCT00001034

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00000980

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00001018

Acupuncture and Moxa: A Randomized Clinical Trial for Chronic Diarrhea in HIV Patients

Condition: HIV Infections

NCT ID: NCT00010491

Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002062

Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance

Condition: HIV; Malaria; Diarrhea; Pneumonia; Opportunistic Infections

NCT ID: NCT00137657

Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults

Condition: Cholera; Vibrio Infections; Diarrhea

NCT ID: NCT00741637

Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients

Condition: HIV Infections

NCT ID: NCT00017823

Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease

Condition: HIV Infections; Gastrointestinal Diseases

NCT ID: NCT00002145

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

Condition: Colitis; HIV Infections

NCT ID: NCT00000768

Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children

Condition: HIV Infections; Cryptosporidiosis

NCT ID: NCT00055107

PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa

Condition: Diarrhea

NCT ID: NCT00397150

The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002264

A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00001081

CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements

Condition: HIV

NCT ID: NCT01313910

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

Condition: HIV Infection; Gastrointestinal Symptoms

NCT ID: NCT01184456

Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002027

Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002328

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002248

A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002158

A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002278

Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients

Condition: HIV Infections; Cryptosporidiosis

NCT ID: NCT00057486

A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea

Condition: HIV Infections

NCT ID: NCT00002444

Botswana Diarrheal Diseases Study

Condition: HIV Infections

NCT ID: NCT00197652

Impact of Serum-derived Bovine Immunoglobulin Protein Isolate, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

Condition: HIV-associated Enteropathy

NCT ID: NCT01828593

Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS

Condition: HIV Infections

NCT ID: NCT00546689

Screening for HIV-Associated Anal Cancer

Condition: HIV Infections; Anal Cancer; Anal Dysplasia; Papillomavirus Infections

NCT ID: NCT00188292

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Condition: Anus Neoplasms; HIV Infections

NCT ID: NCT00428285

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

Condition: Anal Cancer; HIV Infections

NCT ID: NCT00666107

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

Condition: HIV Infections; Anus Neoplasms

NCT ID: NCT00000764

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00000771

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

Condition: Anal Cancer; HIV Infection; Human Papilloma Virus Infection

NCT ID: NCT01946139

Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Condition: HIV Infection; Recurrent Anal Cancer; Recurrent Breast Cancer; Recurrent Esophageal Cancer; Recurrent Gastric Cancer; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage IV Anal Cancer; Stage IV Breast Cancer; Stage IV Esophageal Cancer; Stage IV Gastric Cancer; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT01249443

A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes

Condition: Anemia; Intestinal Helminthiasis; Intestinal Schistosomiasis; Human Immunodeficiency Virus I Infection; Hematologic Diseases; Opportunistic Infections

NCT ID: NCT01541631

Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00002082

A Study of Anal Cancer Development in HIV Infected People

Condition: HIV Infections; Anus Neoplasms

NCT ID: NCT00107679

Plasma Citrulline Concentration in Tropical Enteropathy

Condition: Malabsorption Syndromes; Granulomatous Enteritis; Enteritis; HIV Enteropathy; Ileal Diseases

NCT ID: NCT00816842

A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS

Condition: Colitis; HIV Infections

NCT ID: NCT00002273

Anal Cancer Screening Study

Condition: HIV Infections; Papillomavirus Infections; Anus Neoplasms

NCT ID: NCT00914537

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Condition: Anal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous Condition

NCT ID: NCT01209325

Treatment of Chronic Cryptosporidiosis in AIDS Patients

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00001128

Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00002041

Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events

Condition: HIV; Malnutrition; Cryptosporidiosis

NCT ID: NCT01699841

Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow

Condition: Allergic Rhinitis (Disorder); Asthma; Back Pain; Benign Prostatic Hypertrophy; Bursitis; Depression; Anxiety; Diabetes Mellitus; Esophageal Reflux; HIV Infections; Hyperlipidemia; Hypertension; Insomnia; Irritable Bowel Syndrome; Obesity; Osteoporosis (Senile); Shoulder Pain; Sinusitis; Symptomatic Menopause; Urinary Incontinence; Urinary Tract Infection; Vaginitis

NCT ID: NCT00634608

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

Condition: Candidiasis, Esophageal; HIV Infections

NCT ID: NCT00005921

Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients

Condition: Cryptosporidiosis; HIV Infections

NCT ID: NCT00004986

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Condition: Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; HER2-negative Breast Cancer; HIV-associated Hodgkin Lymphoma; Intraocular Lymphoma; Male Breast Cancer; Nodal Marginal Zone B-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Primary Central Nervous System Hodgkin Lymphoma; Primary Central Nervous System Non-Hodgkin Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Breast Cancer; Recurrent Colon Cancer; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Rectal Cancer; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Colon Cancer; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Rectal Cancer; Stage III Small Lymphocytic Lymphoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Breast Cancer; Stage IV Colon Cancer; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Rectal Cancer; Stage IV Small Lymphocytic Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia

NCT ID: NCT01158274

Effects of Growth Hormone in Chronically Ill Children

Condition: - Hurler Syndrome (MPS-1) With Short Stature and Muscle Wasting; - Cerebral Palsy With Muscle Wasting; - Juvenile Rheumatoid Arthritis With Muscle Wasting and Short Stature; - Crohn’s Disease; - HIV Infection.

NCT ID: NCT00286689

Creon in HIV Patients With Steatorrhea

Condition: Steatorrhea

NCT ID: NCT00623025

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Condition: Anal Cancer; Cervical Cancer; Lung Cancer; Lymphoma; Nonneoplastic Condition

NCT ID: NCT01567722

Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia

Condition: Anal Cancer; Neoplasm of Uncertain Malignant Potential; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT01164722

Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants

Condition: Necrotizing Enterocolitis

NCT ID: NCT01868737

An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users

Condition: Using Cocaine or Heroin in the Last 7 Days,; Age Over 18 Years Old,; Competent to Sign Informed Consent for HIV/HBV/HCV Testing,; HIV/HBV Negatives Will be Randomized for HB Vaccine Study; HIV Infections

NCT ID: NCT00841477

Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV

Condition: Hepatitis B; Hepatitis C; HIV; HIV Infections

NCT ID: NCT00926146

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Condition: HIV; HIV Infections

NCT ID: NCT00358696

Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection - A Positron Emission Tomography (PET) Study

Condition: Acute Hepatitis C; HIV; HIV Infections

NCT ID: NCT00959166

Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)

Condition: HIV-hepatitis Co-infection; HIV Infections

NCT ID: NCT00662194

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Condition: HIV; Hepatitis C; HIV and Hepatitis C Coinfection

NCT ID: NCT01335230

HIV-HBV Co-Infection and Liver Disease

Condition: HIV Infections; HIV-HBV Co-Infection

NCT ID: NCT00637429

Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Condition: Hepatitis C; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00845676

Injecting Drug Use Community Intervention Trial

Condition: HIV; Hepatitis C; Syphilis; HSV-2; HIV Infections

NCT ID: NCT01108614

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

Condition: Chronic Hepatitis C Infection in HIV-Infected Persons; HIV Infections

NCT ID: NCT00215891

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

Condition: Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections

NCT ID: NCT00215839

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

Condition: Human Immunodeficiency Virus (HIV); Hepatitis C, Chronic

NCT ID: NCT01206933

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

Condition: Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome; Hepatitis C

NCT ID: NCT02116179

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00001117

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00879047

Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients

Condition: HIV

NCT ID: NCT01437475

A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis

Condition: Liver Fibrosis; Hepatitis C; HIV; HIV/HCV Co-infection

NCT ID: NCT01707472

Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus

Condition: Acquired Immune Deficiency Syndrome; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; HIV Infections

NCT ID: NCT00499434

Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00158535

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01285050

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

Retrovirus Epidemiology Donor Study-II (REDS-II)

Condition: Acquired Immunodeficiency Syndrome; Blood Donors; Blood Transfusion; HIV Infections; HIV-1; HIV-2; HTLV-I; HTLV-II; Retroviridae Infections; Hepatitis, Viral, Human; Hepatitis B; Hepacivirus; West Nile Virus

NCT ID: NCT00097006

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Condition: Hepatitis C Virus; HIV

NCT ID: NCT02073656

Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01147107

A Study of Zidovudine in HIV-Infected Patients With Liver Disease

Condition: HIV Infections; Liver Diseases

NCT ID: NCT00001001

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00150098

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Condition: HIV Infections; Chronic Hepatitis B

NCT ID: NCT00023153

Control and Eradication Within Australia of Hepatitis C From People Living With HIV

Condition: Hepatitis C; HIV; HIV-HCV Coinfection

NCT ID: NCT02102451

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00100633

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection

Condition: Hepatitis; HIV; Liver Cancer

NCT ID: NCT01350648

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Condition: Chronic HIV Infection; HCV Coinfection

NCT ID: NCT01222611

HIV-HCV Coinfection: Impact of Immune Dysfunction

Condition: HIV Infections; Hepatitis

NCT ID: NCT00575315

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00008463

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01423643

Effects of HIV and Hepatitis C Virus on the Brain

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00494936

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01448915

The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals

Condition: Acute Hepatitis C; HIV Infections

NCT ID: NCT01289652

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention

Condition: HIV Infections; Hepatitis; Sexually Transmitted Infections

NCT ID: NCT01142882

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00001035

HIV and Hepatitis Care Coordination in Methadone Treatment

Condition: Hepatitis, Viral, Human; HIV Infections

NCT ID: NCT00608192

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

Condition: HIV Infection; Hepatitis B

NCT ID: NCT00106964

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00023218

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Condition: Anal Cancer; Precancerous Condition

NCT ID: NCT00066430

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Condition: Hepatitis B Virus; HIV Infections

NCT ID: NCT00476463

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

Condition: HIV Infections; Hepatitis C Virus

NCT ID: NCT01040039

Kidney and Liver Transplantation in People With HIV

Condition: HIV Infections; Kidney Disease; Liver Disease

NCT ID: NCT00074386

Pioglitazone to Treat Fatty Liver in People With HIV Infection

Condition: HIV Infections; Hepatic Steatosis; Insulin Resistance

NCT ID: NCT00441272

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00127959

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

Condition: HIV Infections; Hepatitis B Virus

NCT ID: NCT00660361

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

Condition: Hepatitis C; HIV Infection

NCT ID: NCT00004846

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

Hepatitis B and HIV Co-Infection in Patients in Uganda

Condition: Hepatitis B; HIV Infections

NCT ID: NCT00782158

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

Tenofovir in HIV/HBV Coinfection

Condition: HIV Infection; Hepatitis B Coinfection

NCT ID: NCT00192595

Hepatitis B Vaccination in HIV-infected Persons

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00230061

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01529073

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00132210

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00662545

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

Condition: Hepatitis C; HIV; Anemia

NCT ID: NCT00315432

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00059358

Hepatitis B Vaccination (HBV) in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00886964

Prevalence of Hepatitis C Virus Infection in HIV-Infected Children

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00037076

Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions

Condition: HIV Infections; Fatty Liver

NCT ID: NCT00152815

SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Condition: Anal Cancer

NCT ID: NCT00052897

Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer

Condition: Anal Cancer

NCT ID: NCT00324415

To Determine the Prevalence of HIV and Other Related Infections Such as Hepatitis C, Along With Associated Risk Behaviors, in Patients With Severe Mental Illness (SMI).

Condition: Hepatitis C; HIV Infections; Mental Disorders

NCT ID: NCT00007709

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00085917

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

Condition: Chronic Hepatitis C; Hepatitis C; HIV Infections

NCT ID: NCT00736242

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00018031

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

Condition: Hepatitis C, Chronic; Hepacivirus; HIV Infections

NCT ID: NCT00687544

Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting

Condition: HIV Infections

NCT ID: NCT00222859

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Condition: HIV Infections; Hepatitis C; HCV Infection

NCT ID: NCT00959699

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Condition: HIV Infections; Hepatitis C, Chronic

NCT ID: NCT00122616

Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects

Condition: HIV Infection

NCT ID: NCT01289106

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00530972

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01332955

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01105611

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Condition: Hepatitis C Infection; HIV Infection

NCT ID: NCT01185028

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Condition: HIV Infection; Hepatitis C Infection

NCT ID: NCT00991289

A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00246363

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00480792

HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow Transplantation

Condition: HIV Infection; AIDS; Cirrhosis

NCT ID: NCT01309594

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

Condition: HBV Coinfection; HIV Infections

NCT ID: NCT01318096

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Condition: Hepatitis C, Chronic; HIV Infections

NCT ID: NCT00553930

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Condition: Liver Cirrhosis; Hepatitis C Virus; HIV Infection

NCT ID: NCT01006031

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00612755

Genotype Based Personalized Prescription of Nevirapine

Condition: Nevirapine Induced Rash; Nevirapine Induced Hepatitis; HIV; Adverse Side Effects; AIDS; HIV Infections

NCT ID: NCT00986063

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Condition: HIV Infections; Chronic Hepatitis C

NCT ID: NCT00196586

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Condition: Hepatitis B; HIV Infections

NCT ID: NCT00391638

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Hepatitis C,; Human Immunodeficiency Virus

NCT ID: NCT01667731

Prospective Study of HIV Infection in Hemophiliacs

Condition: Acquired Immunodeficiency Syndrome; HIV Infections; Blood Disease; Hemophilia A; Hepatitis, Viral, Human; Blood Transfusion; Cytomegalovirus Infections

NCT ID: NCT00005309

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Condition: HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis

NCT ID: NCT00013871

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Condition: Hepatitis B; HIV Infection

NCT ID: NCT00670839

Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

Condition: Anal Cancer; Precancerous Condition

NCT ID: NCT00550589

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Condition: HIV Infections; Liver Toxicity; Hepatitis Co-infection

NCT ID: NCT01273142

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

A Study of Azidothymidine in HIV-Infected Children

Condition: Encephalopathies; HIV Infections

NCT ID: NCT00000982

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Condition: HIV Infections

NCT ID: NCT00356486

Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin

Condition: Anemia; Neutropenia; Hepatitis C Virus; HIV Infections

NCT ID: NCT00194857

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

Condition: Chronic Hepatitis B; HIV Infections

NCT ID: NCT00221286

Treatment of Hepatitis C in Hemophilic Patients With HIV

Condition: HIV Infections; Hepatitis C; Hemophilia

NCT ID: NCT00055341

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

Condition: Rotavirus Gastroenteritis

NCT ID: NCT00263666

A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection

Condition: Hepatitis C Virus Infection; Human Immunodeficiency Virus Infection; Chronic Hepatitis C; Compensated Cirrhosis and Non-cirrhotics

NCT ID: NCT01939197

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Condition: Hepatitis B; HIV Infection

NCT ID: NCT00013702

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00296972

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00033163

Study on Immunopathogenesis in HIV and Hepatitis C Coinfection

Condition: HIV Infection; Hepatitis C Infection; Fibrosis; Inflammation

NCT ID: NCT01296529

Therapy to Elevate CD4 Counts in HIV-1 Disease

Condition: HIV Disease

NCT ID: NCT01370018

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Condition: Hepatitis C; Depressive Disorder, Major; Depressive Disorder; Depression; HIV Infections

NCT ID: NCT00655226

Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment

Condition: HIV Infections; Hepatic Impairment

NCT ID: NCT00162097

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Condition: Hepatitis C Virus; Hiv Infections

NCT ID: NCT00503347

Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons

Condition: HIV Infections; Coronary Artery Disease; Non-Alcoholic Fatty Liver Disease

NCT ID: NCT00889577

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00393276

The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU

Condition: Herpes Simplex; HIV Infections; Hepatitis B

NCT ID: NCT00000654

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

Condition: HIV Infections; Hepatic Insufficiency

NCT ID: NCT00144248

CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION

Condition: HCV Coinfection; HIV Infection

NCT ID: NCT01900015

Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing

Condition: Human Immunodeficiency Virus Infection; Hepatitis C

NCT ID: NCT01447680

Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients

Condition: Hepacivirus; HIV Infections

NCT ID: NCT02008214

Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00164060

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C; Liver Disease

NCT ID: NCT00078403

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00983853

Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals

Condition: HIV Infections

NCT ID: NCT00272493

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00470210

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00006643

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00141284

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00015652

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00121017

Brief Intervention for Drug Misuse in the Emergency Department

Condition: Substance Abuse Detection; HIV; Hepatitis B; Hepatitis C; Brief Intervention; HIV Infections

NCT ID: NCT01124591

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

Condition: Hepatitis C; HIV

NCT ID: NCT01427504

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Condition: HCV and HIV Seropositive Coinfection

NCT ID: NCT01718301

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Condition: Human Immunodeficiency Virus; Hepatitis C

NCT ID: NCT01289951

HBV-HIV Coinfection Research Network

Condition: Hepatitis B; Human Immunodeficiency Virus

NCT ID: NCT01924455

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Subjects

Condition: Chronic Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01783678

ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

Condition: HIV Infections; Hepatitis B; Dyslipidemia

NCT ID: NCT00493506

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Condition: Hepatitis C, Chronic; Human Immunodeficiency Virus

NCT ID: NCT02057003

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Condition: Human Immunodeficiency Virus; Chronic Hepatitis C

NCT ID: NCT00909129

Effects of Low-Dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Condition: Hepatitis C; Liver Cirrhosis; HIV Infections

NCT ID: NCT00381017

Improving Blood Safety and HIV Testing in Brazil

Condition: HIV; Herpes Simplex 2; Hepatitis C; Hepatitis B; Chagas Disease

NCT ID: NCT01681420

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Condition: Hepatitis C, Chronic; HIV

NCT ID: NCT01925183

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Condition: Hepatitis B; Human Immunodeficiency Virus; Hepatitis C, Chronic

NCT ID: NCT00782301

Brief Intervention for Rural Women at High Risk for HIV/HCV

Condition: Acquired Immune Deficiency Syndrome Virus; Hepatitis C; Drug Abuse

NCT ID: NCT01840722

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00164372

Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections

Condition: HIV; Hepatitis C; Liver Disease; Fatty Liver; Steatosis

NCT ID: NCT00742326

Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00150904

Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease

Condition: HIV; Hepatitis C

NCT ID: NCT01654939

Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection

Condition: Thrombocytopenia; Hepatitis C; HIV Infections

NCT ID: NCT00239733

A Network & Dyad HIV Prevention Intervention for IDU's - 1

Condition: HIV; Hepatitis

NCT ID: NCT00218335

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Condition: HIV; Hepatitis C; Liver Fibrosis

NCT ID: NCT01231685

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

Condition: HIV; Hepatitis-B

NCT ID: NCT00476723

HCV Treatment in HIV Co-Infected Patients in Asia

Condition: Hepatitis C; HIV

NCT ID: NCT01838772

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1/Hepatitis B Co-infected Adults

Condition: HIV; HBV

NCT ID: NCT02071082

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00545558

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Condition: HIV; Hepatitis C; Infections

NCT ID: NCT00747539

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests

Condition: HIV; Hepatitis B; Hepatitis C; Carcinoma, Hepatocellular; AIDS

NCT ID: NCT01790633

THISTLE - The HIV-HCV Silibinin Trial

Condition: HIV; Hepatitis C

NCT ID: NCT01816490

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00031343

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01818856

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

Condition: Hepatitis B Virus; HIV

NCT ID: NCT02060162

Trial of Citalopram for the Prevention of Depression

Condition: Depression; HIV Infections; Hepatitis C

NCT ID: NCT00317746

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Condition: HIV Infection; Liver Failure; Evidence of Liver Transplantation

NCT ID: NCT01022476

Notification of Donors With Positive Microbiology Markers

Condition: Human Immunodeficiency Virus; Hepatitis B; Hepatitis C; Human T-lymphotropic Virus I & II; Creutzfeldt-Jakob Syndrome; HIV Infections

NCT ID: NCT01050881

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Condition: Non-alcoholic Steatohepatitis; Chronic Liver Disease; HCV; NASH.; HIV Infection; Thrombocytopenia; Hepatitis C Virus; HBV; Human Immunodeficiency Virus; Liver Diseases; Hepatitis B Virus

NCT ID: NCT00678587

A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Condition: HIV Coinfection

NCT ID: NCT01327547

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Dutch Acute HCV in HIV Study (DAHHS)

Condition: Hepatitis C; Human Immunodeficiency Virus

NCT ID: NCT01912495

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Condition: HIV-1 and Hepatitis C Co-Infection

NCT ID: NCT00665353

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Condition: Liver Diseases, Alcoholic; Alcoholism; HIV; Hepatitis C

NCT ID: NCT01410123

Manhattan HIV/Hepatology Brain Bank

Condition: HIV; Hepatitis

NCT ID: NCT00300209

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

Condition: HIV Infections; Hepatitis A; Hepatitis B

NCT ID: NCT00451984

VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer

Condition: Hepatitis C; HCV; HIV; AIDS

NCT ID: NCT00828789

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Condition: Hiv

NCT ID: NCT01751555

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .

Condition: Hepatitis B; HIV

NCT ID: NCT02003703

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Condition: HIV; Hepatitis C

NCT ID: NCT01225705

Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Ribavirin Therapy for Chronic Hepatitis C in Latino Subjects With and Without HIV Co-infection

Condition: Hepatitis C; HIV

NCT ID: NCT01182298

An Open Label Trial of Pegylated Interferon, Ribavirin and Telaprevir Versus Pegylated Interferon and Ribavirin Alone in the Treatment of Hepatitis C Genotype 1 Virus Infection in Patients With HIV-1 Co-infection

Condition: HIV

NCT ID: NCT02006745

Prevalence of Liver Fibrosis and Progression of Liver Fibrosis

Condition: HIV Infection and Chronic Alanine Aminotransferase Elevation

NCT ID: NCT01208376

Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00069498

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in HIV-1 Infected Patients

Condition: Hepatitis; Hepatitis C; Coinfection HCV and HIV

NCT ID: NCT02103439

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Condition: Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic

NCT ID: NCT01908660

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Condition: Chronic Hepatitis C; Co-Infection HIV-HCV

NCT ID: NCT00611819

Immune Response to Hepatitis C Virus

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00165919

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Condition: HIV Infection; Hepatitis B

NCT ID: NCT00142740

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

Condition: Hepatitis B; Hepatitis C; HIV Infection

NCT ID: NCT00001712

Study to Reduce Intravenous Exposures (STRIVE)

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00391482

Genetic Susceptibility to Oncogenic Viruses

Condition: Infection; Liver Neoplasms; HIV Infections

NCT ID: NCT00341484

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Condition: HIV Infections; Hepatitis B Virus

NCT ID: NCT00404989

Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History

Condition: Hepatitis B; HIV Infections

NCT ID: NCT00168194

ADHEPTA Study: Adherence Questionnaire in Hepatitis C

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT00998621

Safety and Acceptability of a Vaginal Microbicide

Condition: HIV Infections; Hepatitis B, Chronic

NCT ID: NCT00111943

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Condition: HIV; Hepatitis C; Syphilis; Herpes Simplex Type II

NCT ID: NCT01315054

Effects of Ribavirin on Zidovudine or Stavudine

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00021632

Risk Assessment of Long-Haul Truck Drivers

Condition: Gonorrhea; Chlamydia Infections; Hepatitis B; Hepatitis C; Diabetes Mellitus; Hypertension; Obesity; HIV Infections; Hyperlipidemia

NCT ID: NCT00381992

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Condition: Acquired Immunodeficiency Syndrome Virus; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; Hepatocellular Carcinoma

NCT ID: NCT02113865

Computer-Assisted Tailored Cue-card Health [CATCH] Study

Condition: Human Immunodeficiency Virus; STDs; Hepatitis, Viral, Human

NCT ID: NCT01170741

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Condition: Hepatitis C Virus Genotype-1

NCT ID: NCT01479868

Transfusion Infections Pediatric Prospective Study (TRIPPS)

Condition: Blood Donors; Blood Transfusion; Cytomegalovirus Infections; Hepatitis, Viral, Human; HIV Infections

NCT ID: NCT00029406

Leukapheresis for Research on HCV-Coinfected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00076427

A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

Condition: Encephalopathy; HIV Infections; Radiculitis

NCT ID: NCT00000856

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

Condition: Hepatitis C Virus; HIV Infections; Pregnancy

NCT ID: NCT00894257

Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467518

Increasing Viral Testing in the Emergency Department

Condition: Drug Use; HIV; Hepatitis C

NCT ID: NCT01419899

Phase III HIV/HCV Co-Infection Daclatasvir (DCV)+ Sofosbuvir (SOF)

Condition: Hepatitis C

NCT ID: NCT02032888

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Condition: Hepatitis C, Chronic

NCT ID: NCT00353418

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Condition: Hepatitis C

NCT ID: NCT01467479

Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus

Condition: Hepatitis C, Genotype 1

NCT ID: NCT01471574

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Condition: Chronic Hepatitis C

NCT ID: NCT01684787

A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-1439 (MK-1439-019)

Condition: HIV-1 Infection

NCT ID: NCT02089659

Fosamprenavir in Pts With Hepatic Impairment

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01054586

Causes of Rotavirus Vaccine Failure in Zambian Children

Condition: Diarrhoea

NCT ID: NCT01886833

CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

Condition: Bone Marrow Failure Syndrome; Severe Aplastic Anemia; Severe Congenital Neutropenia; Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Schwachman Diamond Syndrome; Primary Immunodeficiency Syndromes; Acquired Immunodeficiency Syndromes; Histiocytic Syndrome; Familial Hemophagocytic Lymphocytosis; Lymphohistiocytosis; Macrophage Activation Syndrome; Langerhans Cell Histiocytosis (LCH); Hemoglobinopathies; Sickle Cell Disease; Sickle Cell-beta-thalassemia

NCT ID: NCT01966367

Relative Bioavailability Study of GSK1265744 Formulations

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01648257

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467531

UCLA-Amity Parolee Health Promotion Study

Condition: Hepatitis B; Hepatitis C; HIV; Drug Addiction

NCT ID: NCT01844414

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Condition: Hepatitis C; HIV

NCT ID: NCT01336829

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Condition: Human Immunodeficiency Virus-Infection

NCT ID: NCT01153269

TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

Condition: HIV; AIDS; Hepatic Impairment

NCT ID: NCT00736905

Behavioral Science Aspects of Rapid Test Acceptance

Condition: HIV; Hepatitis C; Hepatitis B; Syphilis

NCT ID: NCT01317784

Multidisciplinary Inpatient Palliative Care Intervention

Condition: Cerebrovascular Accident; Cancer; Coronary Arteriosclerosis; Heart Failure, Congestive; Diabetes Mellitus; Acquired Immunodeficiency Syndrome; Failure to Thrive; Pulmonary Disease, Chronic Obstructive; Dementia; Kidney Failure, Chronic; Pneumonia; Liver Failure; Renal Failure; Respiratory Failure; Stroke

NCT ID: NCT00325611

An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus (C-EDGE COINFECTION) (MK-5172-061)

Condition: Chronic Hepatitis C

NCT ID: NCT02105662

GSK1349572 Hepatic Impairment Study

Condition: Healthy Subjects; Hepatic Impairment; Infection, Human Immunodeficiency Virus

NCT ID: NCT01231529

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Condition: Accelerated Phase Chronic Myelogenous Leukemia; Acute Undifferentiated Leukemia; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Primary CNS Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Eosinophilic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Extramedullary Plasmacytoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Gastrointestinal Stromal Tumor; Intraocular Lymphoma; Isolated Plasmacytoma of Bone; Meningeal Chronic Myelogenous Leukemia; Monoclonal Gammopathy of Undetermined Significance; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Polycythemia Vera; Previously Treated Myelodysplastic Syndromes; Primary Central Nervous System Non-Hodgkin Lymphoma; Primary Myelofibrosis; Primary Systemic Amyloidosis; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Unspecified Adult Solid Tumor, Protocol Specific; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia

NCT ID: NCT00025415

The Health Access and Recovery Peer Program

Condition: Hypertension; Arthritis; Coronary Artery Disease; Hepatitis; Diabetes; Asthma; Hyperlipidemia; HIV

NCT ID: NCT01725815

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Condition: Hepatitis C; Telaprevir; HIV

NCT ID: NCT00775125

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

Condition: Visceral Leishmaniasis; Human African Trypanosomiasis; Enteric Fever; Melioidosis; Brucellosis; Leptospirosis; Relapsing Fever; Rickettsial Diseases; HIV; Tuberculosis; Malaria; Amoebic Liver Abscess

NCT ID: NCT01766830

Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients

Condition: Opioid Dependence; Hepatitis; HIV

NCT ID: NCT01645033

Preliminary Evaluation of a Point-Of-Care Liver Function Test

Condition: HIV; Tuberculosis; Drug-Induced Liver Injury

NCT ID: NCT01705041

Chronic Hepatitis Intervention Project for Drug Users

Condition: HIV; Hepatitis C

NCT ID: NCT00596843

Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)

Condition: HIV; Hepatitis C

NCT ID: NCT00794391

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults

Condition: Hepatitis c

NCT ID: NCT01472354

Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy

Condition: Liver Fibrosis

NCT ID: NCT00326482

Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths

Condition: Hepatitis B

NCT ID: NCT00107042

Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV

Condition: Steatohepatitis

NCT ID: NCT00575757

HIV Accelerated Liver Disease in Uganda

Condition: Fibrosis

NCT ID: NCT01524562

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Condition: Hepatitis C, Chronic; Co-Infection

NCT ID: NCT01878799

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Condition: Chronic Hepatitis C Infection

NCT ID: NCT01866930

Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women

Condition: Vertical Disease Transmission; HBV

NCT ID: NCT02044068

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

Condition: Hepatitis C

NCT ID: NCT01647191

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Condition: Hepatitis B

NCT ID: NCT00051038

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Condition: Hepatitis

NCT ID: NCT00901524

MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)

Condition: Hepatitis C

NCT ID: NCT00857311

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Inmunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Condition: Hepatitis C, Chronic

NCT ID: NCT01399619

Telaprevir Open-Label Study in Co-Infected Patients

Condition: Hepatitis C, Chronic

NCT ID: NCT01500616

A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection

Condition: Hepatitis B Virus

NCT ID: NCT00476411

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

Condition: Hepatitis C

NCT ID: NCT00703560

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Condition: Pancreatic Neoplasms

NCT ID: NCT01086332

Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer

Condition: Adenocarcinoma of the Pancreas; Stage III Pancreatic Cancer

NCT ID: NCT01068327

Combination Chemotherapy With or Without Oregovomab and Stereotactic Radiotherapy Together With Nelfinavir Mesylate in Treating Patients With Localized or Locally Advanced Pancreatic Cancer

Condition: Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer

NCT ID: NCT01959672

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Condition: Chronic Hepatitis C

NCT ID: NCT00526448

Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men

Condition: Anal Cancer; Nonneoplastic Condition; Precancerous Condition

NCT ID: NCT00955591

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Condition: Hodgkin Lymphoma; Non Hodgkin Lymphoma; Kaposi's Sarcoma; Gastric Cancer; Nasopharyngeal Cancer

NCT ID: NCT00982449

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Condition: Lung Cancer; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific

NCT ID: NCT00734890

The Second Multicenter Hemophilia Cohort Study

Condition: Liver Decompensation; Hepatocellular Carcinoma; Non-Hodgkin Lymphoma

NCT ID: NCT00341705

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Condition: Chronic Hepatitis C; Chronic Hepatitis B

NCT ID: NCT00225537

Intensive Models of HCV Care for Injection Drug Users

Condition: Hepatitis C; Medication Adherence

NCT ID: NCT01857245

A Controlled Prospective Study of Transfusion-Associated Hepatitis

Condition: Hepatitis

NCT ID: NCT00004848

Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection

Condition: Hepatitis

NCT ID: NCT01102296